Twin Tree Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,465
Closed -$349K 1878
2025
Q1
$328K Buy
+1,465
New +$342K ﹤0.01% 1366
2024
Q2
Sell
-42,946
Closed -$8.71M 1618
2024
Q1
$8.5M Sell
42,946
-88,437
-67% -$16.2M 0.02% 688
2023
Q4
$22.6M Buy
+131,383
New +$20.2M 0.04% 433
2023
Q3
Sell
-19,313
Closed -$4.22M 1482
2023
Q2
$4.22M Buy
+19,313
New +$4.3M 0.01% 798
2022
Q3
Sell
-8,053
Closed -$1.69M 1645
2022
Q2
$1.69M Buy
8,053
+5,720
+245% +$1.22M ﹤0.01% 1113
2022
Q1
$566K Buy
+2,333
New +$564K ﹤0.01% 1365
2021
Q2
Sell
-11,835
Closed -$2.49M 1576
2021
Q1
$2.3M Buy
11,835
+7,211
+156% +$1.45M 0.01% 818
2020
Q4
$983K Sell
4,624
-864
-16% -$172K ﹤0.01% 974
2020
Q3
$941K Buy
+5,488
New +$1.01M ﹤0.01% 904
2020
Q2
Sell
-18,964
Closed -$3.1M 1666
2020
Q1
$2.79M Buy
18,964
+4,495
+31% +$716K 0.01% 637
2019
Q4
$2.24M Sell
14,469
-31,533
-69% -$4.54M 0.01% 692
2019
Q3
$6.21M Sell
46,002
-26,544
-37% -$3.48M 0.02% 427
2019
Q2
$8.85M Sell
72,546
-18,165
-20% -$2.01M 0.04% 328
2019
Q1
$9.43M Buy
90,711
+62,008
+216% +$6.4M 0.05% 307
2018
Q4
$3.27M Buy
28,703
+28,025
+4,133% +$3M 0.02% 605
2018
Q3
$78K Buy
678
+673
+13,460% +$73.7K ﹤0.01% 969
2018
Q2
$1K Buy
+5
New +$506 ﹤0.01% 1104
2017
Q3
Sell
-2,946
Closed -$229K 1142
2017
Q2
$229K Buy
+2,946
New +$211K ﹤0.01% 806
2017
Q1
Sell
-71,535
Closed -$4.44M 1222
2016
Q4
$4.44M Buy
+71,535
New +$4.38M 0.04% 418
2016
Q2
Sell
-1,622
Closed -$94K 1369
2016
Q1
$94K Buy
1,622
+1,428
+736% +$80.8K ﹤0.01% 1103
2015
Q4
$10K Buy
+194
New +$10.9K ﹤0.01% 1340

Other funds holding RMD

Twin Tree Management's RMD Position: Q2 2025 in Review

Twin Tree Management sold out of ResMed (RMD) in Q2 2025, closing a stake of 1,465 shares — an estimated $349K sold.

Twin Tree Management first reported a position in RMD in Q4 2015 and held it in 21 quarters. The position peaked at $22.6M in Q4 2023. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • Twin Tree Management reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
  • Twin Tree Management sold 1,465 ResMed shares in Q2 2025, an estimated $349K.
  • Twin Tree Management first reported a position in ResMed in Q4 2015 and held it in 21 quarters.
  • Twin Tree Management's ResMed position peaked at $22.6M in Q4 2023.
  • 919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Twin Tree Management's 13F filing for Q2 2025, filed 28 Jul 2025.